Skip Navigation
Skip to contents



13 results

Response: Trends in Hyperglycemic Crisis Hospitalizations and in- and out-of-Hospital Mortality in the Last Decade Based on Korean National Health Insurance Claims Data (Endocrinol Metab 2019;34:275–81, Ji Hong You et al.)

You JH, Song SO

  • Endocrinol Metab.
  • 2019 Dec;34(4):424-425.
  • doi: 10.3803/EnM.2019.34.4.424
No abstract available.
Letter: Trends in Hyperglycemic Crisis Hospitalizations and in- and out-of-Hospital Mortality in the Last Decade Based on Korean National Health Insurance Claims Data (Endocrinol Metab 2019;34:275–81, Ji Hong You et al.)

Son JW

  • Endocrinol Metab.
  • 2019 Dec;34(4):422-423.
  • doi: 10.3803/EnM.2019.34.4.422
No abstract available.
Revisiting Rupture of Benign Thyroid Nodules after Radiofrequency Ablation: Various Types and Imaging Features

Chung SR, Baek JH, Sung JY, Ryu JH, Jung SL

  • Endocrinol Metab.
  • 2019 Dec;34(4):415-421.
  • doi: 10.3803/EnM.2019.34.4.415
BACKGROUND: To evaluate the imaging features, clinical manifestations, and prognosis of patients with thyroid nodule rupture after radiofrequency ablation (RFA). METHODS: The records of 12 patients who experienced thyroid nodule rupture...
Impact of the Dynamic Change of Metabolic Health Status on the Incident Type 2 Diabetes: A Nationwide Population-Based Cohort Study

Kim JA, Kim DH, Kim SM, Park YG, Kim NH, Baik SH, Choi KM, Han K, Yoo HJ

  • Endocrinol Metab.
  • 2019 Dec;34(4):406-414.
  • doi: 10.3803/EnM.2019.34.4.406
BACKGROUND: Metabolically healthy obese (MHO) is regarded as a transient concept. We examined the effect of the dynamic change of metabolic health status on the incidence of type 2 diabetes...
Short-Term Effects of Beraprost Sodium on the Markers for Cardiovascular Risk Prediction in Type 2 Diabetic Patients with Microalbuminuria

Choi YM, Kwon HS, Choi KM, Lee WY, Hong EG

  • Endocrinol Metab.
  • 2019 Dec;34(4):398-405.
  • doi: 10.3803/EnM.2019.34.4.398
BACKGROUND: To evaluate the changes in cardiovascular risk markers including pulse wave velocity (PWV), microalbuminuria, inflammatory cytokines, and adhesion molecules after treatment with beraprost sodium (BPS) in patients with diabetic...
Association between Serum Gamma-Glutamyltransferase and Prevalence of Metabolic Syndrome Using Data from the Korean Genome and Epidemiology Study

Lee MY, Hyon DS, Huh JH, Kim HK, Han SK, Kim JY, Koh SB

  • Endocrinol Metab.
  • 2019 Dec;34(4):390-397.
  • doi: 10.3803/EnM.2019.34.4.390
BACKGROUND: The aim of this study was to determine whether there is a positive correlation between gamma-glutamyltransferase (GGT) levels and the prevalence of metabolic syndrome and whether GGT can be...
Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes

Jang HN, Yang YS, Lee SO, Oh TJ, Koo BK, Jung HS

  • Endocrinol Metab.
  • 2019 Dec;34(4):382-389.
  • doi: 10.3803/EnM.2019.34.4.382
BACKGROUND: Conflicting results have been reported on the efficacy of insulin degludec/insulin aspart (IDegAsp) compared to basal insulin in type 2 diabetes. We investigated the effects of changing basal insulin...
The Modified Ferriman-Gallwey Score and Hirsutism among Filipino Women

Ilagan MK, Paz-Pacheco E, Totesora D, Clemente-Chua LR, Jalique JR

  • Endocrinol Metab.
  • 2019 Dec;34(4):374-381.
  • doi: 10.3803/EnM.2019.34.4.374
BACKGROUND: The modified Ferriman-Gallwey (mFG) score is the gold standard for the clinical evaluation of hirsutism. However, racial variations in terminal hair growth limit this tool. This study aimed to...
Impact of Subtotal Parathyroidectomy on Clinical Parameters and Quality of Life in Hemodialysis Patients with Secondary Hyperparathyroidism

El-kholey , Ibrahim GE, Elshahat O, El-Kannishy G

  • Endocrinol Metab.
  • 2019 Dec;34(4):367-373.
  • doi: 10.3803/EnM.2019.34.4.367
BACKGROUND: Impairment of quality of life (QOL) is a key clinical characteristic of patients with end-stage renal disease (ESRD), and can be especially severe in the presence of secondary hyperparathyroidism...
Molecular Mechanisms of Primary Aldosteronism

Tevosian S, Fox SC, Ghayee HK

  • Endocrinol Metab.
  • 2019 Dec;34(4):355-366.
  • doi: 10.3803/EnM.2019.34.4.355
Primary aldosteronism (PA) results from excess production of mineralocorticoid hormone aldosterone by the adrenal cortex. It is normally caused either by unilateral aldosterone-producing adenoma (APA) or by bilateral aldosterone excess...
Medical Big Data Is Not Yet Available: Why We Need Realism Rather than Exaggeration

Kim HS, Kim DJ, Yoon KH

  • Endocrinol Metab.
  • 2019 Dec;34(4):349-354.
  • doi: 10.3803/EnM.2019.34.4.349
Most people are now familiar with the concepts of big data, deep learning, machine learning, and artificial intelligence (AI) and have a vague expectation that AI using medical big data...
Bisphenols and Thyroid Hormone

Kim MJ, Park YJ

  • Endocrinol Metab.
  • 2019 Dec;34(4):340-348.
  • doi: 10.3803/EnM.2019.34.4.340
In recent decades, attention has been directed toward the effects of bisphenol A (BPA) on human health. BPA has estrogenic activity and is regarded as a representative endocrine disruptor. In...
Intraoperative Parathyroid Hormone Monitoring in the Surgical Management of Sporadic Primary Hyperparathyroidism

Khan ZF, Lew JI

  • Endocrinol Metab.
  • 2019 Dec;34(4):327-339.
  • doi: 10.3803/EnM.2019.34.4.327
Intraoperative parathyroid hormone monitoring (IPM) has been shown to be a useful adjunct during parathyroidectomy to ensure operative success at many specialized medical centers worldwide. Using the Miami or “>50%...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: